Gallbladder disorders, including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation), have also been reported with GLP-1 receptor agonists
As a GLP-1 receptor agonist, it mimics the body's own hormone GLP-1 (glucagon-like peptide-1) and selectively binds to the GLP-1 receptor, thereby stimulating the secretion of insulin and lowering blood glucose levels [15]
10.1111/cas.12891 Cancer Sci
Clinical evidence demonstrates that semaglutide typically improves liver enzyme profiles, particularly in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
This is a clinically meaningful improvement and stands in stark opposition to the results for primary insomnia
A Phase I/II clinical trial (NCT00736476) assessed the efficacy of a vaccine composed of vacuolating cytotoxin A (VacA), cytotoxin-associated antigen (CagA), and neutrophil-activating protein (NAP) for preventing infection with cagA-positive strains post-intramuscular immunization